Pancreatectomy Surgery
Conditions
Interventions
Group PG: Pancreatogastric anastomois of the pancreatic remnant to the stomach
Group PJ: Pancreatojejunostomy anastomois of the pancreatic remnant to the jejunum
Sponsors
Carlos III Institute of Health (Instituto de Salud Carlos III) (Spain)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Consecutive patients who will undergo pancreatodudodenectomy (DPC) at Hospital Clinico de Valencia and Hospital ?Dr Josep Trueta? in Girona Spain. Coordinated by ?Dr Josep Trueta? Hospital of Girona 2. Patients aged 18 to 80 years, either sex 3. Pancreatectomy is indicated because of a benign or malignant tumour of the pancreas, chronic pancreatitis or malignant neoplasm of other organs infiltrating the pancreas, provided the parenchyma of the pancreas is suitable for anastomosis
Exclusion criteria
Exclusion criteria: 1. Patients who at the time of surgery are found not resectable 2. Associated resection of other organs, excluding the superior mesenteric vein 3. American Society of Anaesthesiologists (ASA) anesthetic risk 4 as the American Association of Anesthesiologists 4. Pancreatoduodenectomy (PD) for calcifying chronic pancreatitis 5. PD palliative leaving macroscopic tumor 6. Preoperative obstructive jaundice with bilirubin> 300µmol or 15 mg/L
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of pancreatic fistula, evaluated at the time of hospital discharge and at 3 months post-operatively. The severity of the PF will be evaluated with the ISGPH score. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Mortality and morbidity 2. Complications graded according to Dindo-Clavien classification 3. Reoperation rate 4. Readmissions and hospital stay Evaluated at the time of hospital discharge and at 3 months post-operatively. | — |
Countries
Spain
Outcome results
None listed